StonvexLoading…
StonvexStonvexStonvexCore line items from ORA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $989.54M | $879.65M | $829.42M | $734.16M |
Operating Income | $169.22M | $172.47M | $166.59M | $152.80M |
Net Income | $123.90M | $123.73M | $124.40M | $65.84M |
EPS (Diluted) | $2.02 | $2.04 | $2.08 | $1.17 |
Total Assets | $6.25B | $5.67B | $5.21B | $4.61B |
Total Liabilities | $3.56B | $3.11B | $2.76B | $2.58B |
Cash & Equivalents | $147.45M | $94.39M | $195.81M | $95.87M |
Free Cash Flow OCF − CapEx | $-284.68M | $-76.76M | $-308.98M | $-282.50M |
Shares Outstanding | 60.50M | 60.50M | 60.36M | 56.10M |